You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ART first-line failure

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Dysfunction Trial in Assiut

Recruiting
  • Thyroid Dysfunction
    • Assiut, Egypt
      Heba Ali
    Feb 2, 2023

    Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)

    Completed
    • Retinitis Pigmentosa
    • Stem Cell Transplant
    • Stem cell implantation
    • Istanbul, Turkey
      Acıbadem University
    Jan 25, 2023

    HIV, Tuberculosis Trial in Dire Dawa, Harar (Combination intervention components, Isoniazid Prevention Therapy)

    Completed
    • HIV
    • Tuberculosis
    • Combination intervention components
    • Isoniazid Prevention Therapy
    • Dire Dawa, Ethiopia
    • +9 more
    Jul 12, 2021

    Multiple Myeloma Trial in Beverly Hills (Elranatamab, Carfilzomib)

    Recruiting
    • Multiple Myeloma
    • Beverly Hills, California
      Beverly Hills Cancer Center
    Dec 21, 2022

    Analgesia, Post-Operative Pain, Breakthrough Pain Trial in Burlington (Non-Narcotic ERAS Post-Operative Pain Management)

    Recruiting
    • Analgesia
    • +3 more
    • Non-Narcotic ERAS Post-Operative Pain Management
    • Burlington, Vermont
      UVM Medical Center
    May 17, 2022

    Psoriasis Vulgaris Trial in Leiden (Guselkumab, Placebos)

    Recruiting
    • Psoriasis Vulgaris
    • Leiden, Netherlands
      Centre for Human Drug Research
    Jun 11, 2021

    Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

    Recruiting
    • Cholangiocarcinoma
    • Ivosidenib Oral Tablet
    • Düsseldorf, Germany
      Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
    May 17, 2023

    Neonatal Respiratory Failure Trial in Cairo (Normal saline)

    Recruiting
    • Neonatal Respiratory Failure
    • Normal saline
    • Cairo, Egypt
      AinShams University Hospitals
    Jan 18, 2022

    Hypoxemia Trial in Jinan (Non-invasive BiPAP ventilation, HFNC)

    Not yet recruiting
    • Hypoxemia
    • Non-invasive BiPAP ventilation
    • HFNC
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Mar 13, 2023

    s Post-cesarean paiN manaGemenet (KING)

    Recruiting
    • Post Cesarean Pain
    • Columbus, Ohio
      The Ohio State University Wexner Medical Center OB/GYN Maternal
    Jun 28, 2022

    Gliomas Trial in New York (Topotecan, Gadolinium, Synchromed II infusion pumps)

    Completed
    • Gliomas
    • New York, New York
      Columbia University Irving Medical Center
    Jun 30, 2022

    Post-operative Pain, Symptomatic Irreversible Pulpitis Trial in Karachi (Sodium hypochlorite 5.25%, Propolis 20%)

    Recruiting
    • Post-operative Pain
    • Symptomatic Irreversible Pulpitis
    • Sodium hypochlorite 5.25%
    • Propolis 20%
    • Karachi, Sindh, Pakistan
      Dow International Dental College
    Jul 26, 2023

    Schizophrenia Trial (Cognitive Enhancement Therapy, Social Skills Training)

    Recruiting
    • Schizophrenia
    • Cognitive Enhancement Therapy
    • Social Skills Training
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Oct 27, 2022

    COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

    Active, not recruiting
    • COVID-19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
    • Yancheng, Jiangsu, China
      Funing Center for Disease Control and Prevention
    Oct 28, 2022

    Miscarriage, Recurrent Trial in Kuala Lumpur (GNRH Analoge, Duphaston, Letrozole)

    Completed
    • Miscarriage, Recurrent
    • GNRH Analoge, Duphaston, Letrozole
    • Kuala Lumpur, Malaysia
      UniversitiKMMC
    Jun 24, 2022

    Chronic Kidney Disease, Hypertension Trial in Houston (Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide,

    Not yet recruiting
    • Chronic Kidney Disease
    • Hypertension
    • Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)
    • Houston, Texas
      Michael E. DeBakey VA Medical Center, Houston, TX
    Aug 3, 2022

    Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Colorectal Cancer Trial in United States (Usual chemo

    Completed
    Has Results
    • Metastatic Pancreatic Cancer
    • +2 more
    • Usual chemotherapy education (CE)
    • Chemotherapy education intervention (CEI)
    • Tampa, Florida
    • +4 more
    Dec 21, 2021

    Concussion, Brain Trial in Fort Bragg (Active Rehab (Group 2), Progressive Return to Activity (Group 1))

    Not yet recruiting
    • Concussion, Brain
    • Active Rehab (Group 2)
    • Progressive Return to Activity (Group 1)
    • Fort Bragg, North Carolina
    • +1 more
    Jan 11, 2023

    Maternal Health Services, Outcome Assessment Trial in Kano (Cash transfer in prior study)

    Active, not recruiting
    • Maternal Health Services
    • Outcome Assessment
    • Cash transfer in prior study
    • Kano, Nigeria
      Amino Kano Teaching Hospital
    Jan 23, 2023

    Sepsis, Septic Shock Trial in Moscow (Efferon LPS NEO)

    Recruiting
    • Sepsis
    • Septic Shock
    • Efferon LPS NEO
    • Moscow, Russian Federation
      Filatov Children's City Clinical Hospital of the Moscow Health D
    Jan 28, 2023

    Healthy Subjects Trial in Shanghai (IBI353 (Orismilast), )

    Not yet recruiting
    • Healthy Subjects
    • IBI353 (Orismilast)
    • placebo
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Aug 4, 2022

    Optimum Time for Intravenous Cannulation in Dexmedetomidine

    Completed
    • Cannulation
    • +2 more
    • Optimum time for intravenous cannulation in children premedicated with dexmedetomidine
    • Karaman, Turkey
      Karaman Taining and Research Hospital
    Feb 4, 2022

    Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo

    Recruiting
    • Heart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2
    • Fairhope, Alabama
    • +103 more
    Mar 17, 2022

    Gastric Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial (Anlotinib Hydrochloride With Nivolumab)

    Unknown status
    • Gastric Adenocarcinoma
    • Esophageal Squamous Cell Carcinoma
    • Anlotinib Hydrochloride With Nivolumab
    • (no location specified)
    Aug 5, 2020

    Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)

    Not yet recruiting
    • Nephrotic Syndrome
    • Dapagliflozin and Standard therapy (ACEI or ARB).
    • Standard Therapy (ACEI or ARB).
    • (no location specified)
    Jul 26, 2023